Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Matinas Biopharma Holdings, Inc. (MTNB) had Return on Investments of -26.37% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-1.66M |
|
-- |
|
-- |
|
$1.95M |
|
$-1.95M |
|
$0.29M |
|
$-1.66M |
|
$-1.66M |
|
$-1.66M |
|
$-1.66M |
|
$-1.66M |
|
$-1.66M |
|
$-1.95M |
|
$-1.82M |
|
5.09M |
|
5.09M |
|
$-0.33 |
|
$-0.33 |
|
| Balance Sheet Financials | |
$7.55M |
|
$0.45M |
|
$4.49M |
|
$12.04M |
|
$2.25M |
|
$0.01M |
|
$3.51M |
|
$5.76M |
|
$6.27M |
|
$6.27M |
|
$6.27M |
|
5.09M |
|
| Cash Flow Statement Financials | |
$-2.01M |
|
-- |
|
$1.65M |
|
$7.53M |
|
$7.17M |
|
$-0.36M |
|
$0.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.35 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-26.41% |
|
-26.41% |
|
-13.76% |
|
|
Return on Investments |
-26.37% |
$1.23 |
|
$-0.39 |
|
$-0.39 |
|